• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强效组蛋白去乙酰化酶抑制剂FK228(FR-901228)的改进全合成

Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228).

作者信息

Greshock Thomas J, Johns Deidre M, Noguchi Yasuo, Williams Robert M

机构信息

Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523, USA.

出版信息

Org Lett. 2008 Feb 21;10(4):613-6. doi: 10.1021/ol702957z. Epub 2008 Jan 19.

DOI:10.1021/ol702957z
PMID:18205373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3097137/
Abstract

A scaleable synthesis of the potent histone deacetylase (HDAC) inhibitor FK228 is described. A reliable strategy for preparing the key beta-hydroxy mercapto heptenoic acid partner was accomplished in nine steps and 13% overall yield. A Noyori asymmetric hydrogen-transfer reaction established the hydroxyl stereochemistry in >99:1 er via the reduction of a propargylic ketone.

摘要

描述了强效组蛋白脱乙酰酶(HDAC)抑制剂FK228的可扩展合成方法。通过九个步骤实现了制备关键的β-羟基巯基庚烯酸部分的可靠策略,总产率为13%。通过诺伊里不对称氢转移反应,通过还原炔丙基酮以>99:1的对映体过量建立了羟基立体化学。

相似文献

1
Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228).强效组蛋白去乙酰化酶抑制剂FK228(FR-901228)的改进全合成
Org Lett. 2008 Feb 21;10(4):613-6. doi: 10.1021/ol702957z. Epub 2008 Jan 19.
2
Development of an efficient solid-phase synthetic methodology to construct a combinatorial library of a potent HDAC inhibitor.开发一种高效的固相合成方法以构建一种强效组蛋白去乙酰化酶(HDAC)抑制剂的组合文库。
Adv Exp Med Biol. 2009;611:17-8. doi: 10.1007/978-0-387-73657-0_8.
3
Total synthesis of spiruchostatin B, a potent histone deacetylase inhibitor, from a microorganism.从一种微生物中全合成强效组蛋白去乙酰化酶抑制剂螺旋抑素B。
Chem Commun (Camb). 2008 Apr 14(14):1677-9. doi: 10.1039/b718310k. Epub 2008 Feb 5.
4
Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor.拉戈唑的全合成及其生物学作用模式:一种强效的I类组蛋白去乙酰化酶抑制剂
J Am Chem Soc. 2008 Aug 20;130(33):11219-22. doi: 10.1021/ja8033763. Epub 2008 Jul 19.
5
Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.组蛋白去乙酰化酶抑制剂拉加唑的全合成及分子靶点
J Am Chem Soc. 2008 Jul 2;130(26):8455-9. doi: 10.1021/ja8013727. Epub 2008 May 29.
6
Total synthesis of spiruchostatin B aided by an automated synthesizer.全自动合成仪辅助下的螺旋甾丁菌素 B 的全合成。
Org Biomol Chem. 2011 May 21;9(10):3825-33. doi: 10.1039/c0ob01169j. Epub 2011 Mar 29.
7
Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor.强效组蛋白去乙酰化酶抑制剂螺旋抑素A的全合成
J Am Chem Soc. 2004 Feb 4;126(4):1030-1. doi: 10.1021/ja039258q.
8
Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities.双环缩肽螺旋菌 C 和 D 的全合成及对组蛋白去乙酰化酶抑制和抗增殖活性的研究。
Eur J Med Chem. 2013 Feb;60:295-304. doi: 10.1016/j.ejmech.2012.12.023. Epub 2012 Dec 21.
9
Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.罗米地辛(FK228)及其类似物作为新型组蛋白去乙酰化酶/磷脂酰肌醇-3-激酶双重抑制剂的生化、生物学及结构特性
Cancer Sci. 2015 Feb;106(2):208-15. doi: 10.1111/cas.12585. Epub 2015 Jan 28.
10
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.FK228的首批具有生物活性的合成类似物,即环肽组蛋白脱乙酰酶抑制剂。
J Med Chem. 2007 Nov 15;50(23):5720-6. doi: 10.1021/jm0703800. Epub 2007 Oct 24.

引用本文的文献

1
Glycosylation and Acylation: Important Regulators of Immune Cell Fate Decisions.糖基化与酰化:免疫细胞命运决定的重要调节因子
Biology (Basel). 2025 May 27;14(6):611. doi: 10.3390/biology14060611.
2
Regioselective and enantioselective propargylic hydroxylations catalyzed by P450tol monooxygenases.由P450tol单加氧酶催化的区域选择性和对映选择性炔丙基羟基化反应。
Bioresour Bioprocess. 2024 Jul 2;11(1):64. doi: 10.1186/s40643-024-00771-7.
3
Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology.人诱导多能干细胞心肌细胞作为研究电生理表观遗传修饰剂的实验模型。
Cells. 2022 Jan 7;11(2):200. doi: 10.3390/cells11020200.
4
Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma.罗米地辛单药治疗难治性皮下脂膜炎样T细胞淋巴瘤取得完全缓解。
JAAD Case Rep. 2020 Oct 7;6(12):1245-1247. doi: 10.1016/j.jdcr.2020.09.018. eCollection 2020 Dec.
5
Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228.基于基因组学发现一种全新且明显更优的抗癌天然药物FK228来源。
Synth Syst Biotechnol. 2018 Nov 5;3(4):268-274. doi: 10.1016/j.synbio.2018.10.011. eCollection 2018 Dec.
6
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.组蛋白去乙酰化酶抑制剂罗米地辛作为治疗肺纤维化的潜在药物。
Oncotarget. 2017 Jul 25;8(30):48737-48754. doi: 10.18632/oncotarget.17114.
7
Microbial natural products: molecular blueprints for antitumor drugs.微生物天然产物:抗肿瘤药物的分子蓝图。
J Ind Microbiol Biotechnol. 2013 Nov;40(11):1181-210. doi: 10.1007/s10295-013-1331-1. Epub 2013 Sep 3.
8
Case studies of the synthesis of bioactive cyclodepsipeptide natural products.生物活性环二肽天然产物合成的案例研究。
Molecules. 2013 Jan 24;18(2):1337-67. doi: 10.3390/molecules18021337.
9
FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.FK228类似物在人红系祖细胞中诱导胎儿血红蛋白生成。
Anemia. 2012;2012:428137. doi: 10.1155/2012/428137. Epub 2012 May 14.
10
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma.罗米地辛(Istodax,NSC630176,FR901228,FK228,depsipeptide):一种新型天然产物药物,最近获批用于治疗皮肤 T 细胞淋巴瘤。
J Antibiot (Tokyo). 2011 Aug;64(8):525-31. doi: 10.1038/ja.2011.35. Epub 2011 May 18.

本文引用的文献

1
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.FK228的首批具有生物活性的合成类似物,即环肽组蛋白脱乙酰酶抑制剂。
J Med Chem. 2007 Nov 15;50(23):5720-6. doi: 10.1021/jm0703800. Epub 2007 Oct 24.
2
Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors.组蛋白去乙酰化酶抑制剂缩肽环肽对转移性神经内分泌肿瘤患者的心脏毒性
Clin Cancer Res. 2006 Jul 1;12(13):3997-4003. doi: 10.1158/1078-0432.CCR-05-2689.
3
Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma.组蛋白去乙酰化酶抑制剂FK228通过上调Rap1抑制Ras-MAP激酶信号通路并诱导恶性黑色素瘤细胞凋亡。
Oncogene. 2006 Jan 26;25(4):512-24. doi: 10.1038/sj.onc.1209072.
4
Total synthesis of RK-397.RK-397的全合成。
J Am Chem Soc. 2005 Jun 29;127(25):8971-3. doi: 10.1021/ja052226d.
5
Histone deacetylase inhibitors.组蛋白去乙酰化酶抑制剂
Adv Cancer Res. 2004;91:137-68. doi: 10.1016/S0065-230X(04)91004-4.
6
Histone deacetylase inhibitors--a new tool to treat cancer.组蛋白去乙酰化酶抑制剂——一种治疗癌症的新工具。
Cancer Treat Rev. 2004 Aug;30(5):461-72. doi: 10.1016/j.ctrv.2004.04.006.
7
Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor.强效组蛋白去乙酰化酶抑制剂螺旋抑素A的全合成
J Am Chem Soc. 2004 Feb 4;126(4):1030-1. doi: 10.1021/ja039258q.
8
Total synthesis of the depsipeptide FR-901375.缩肽FR-901375的全合成
J Org Chem. 2003 Nov 14;68(23):8902-5. doi: 10.1021/jo034765b.
9
IMDA-radical cyclization approach to (+)-himbacine.用于(+)-喜巴辛的IMDA自由基环化方法。
Org Lett. 2003 Oct 2;5(20):3603-6. doi: 10.1021/ol0353058.
10
FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.FK228(缩肽素)作为一种抑制I类组蛋白脱乙酰酶的天然前体药物。
Cancer Res. 2002 Sep 1;62(17):4916-21.